
|Articles|March 12, 2014
- Immunotherapy (Issue 2)
- Volume 2
- Issue 1
The Future of Immunotherapy Treatments in Lung Cancer
Author(s)Balazs Halmos, MD
Balazs Halmos, MD, section chief of Thoracic Oncology at NewYork-Presbyterian Hospital/Columbia University Medical Center, discusses the future of immunotherapy treatments.
Balazs Halmos, MD, section chief of Thoracic Oncology at NewYork-Presbyterian Hospital/Columbia University Medical Center, discusses the future of immunotherapy treatments in lung cancer.
Read more about immunotherapies for lung and other cancers > >
Articles in this issue
about 12 years ago
The Outlook for CAR-Modified T Cellsabout 12 years ago
B-Cell Malignancies Faring Well With Immunotherapiesabout 12 years ago
Update on Immunotherapy and Targeted Combination Therapiesabout 12 years ago
How Immunotherapies are Changing the Treatment of Melanomaabout 12 years ago
Progress Made With PD-L1 as Predictive Biomarkerabout 12 years ago
Oncolytic Viral Therapies About to Spreadabout 12 years ago
Checking in on Checkpoint Inhibitors



























